ORKA - Oruka Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 27.48

Open

$ 26.29

Bid

$ 25.00 x 3

Ask

$ 28.04 x 5

Day's Range

$ 25.40 - $ 27.67

52 Week Range

$ 5.49 - $ 31.13

Volume

332,129

Average Volume

Market Cap

Beta (5Y Monthly)

$ 0.61

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-06-2025	01-01-1970	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	04-25-2024	03-31-2024	10-Q
7	02-01-2024	12-31-2023	10-K
8	10-18-2023	09-30-2023	10-Q
9	07-21-2023	06-30-2023	10-Q
10	04-24-2023	03-31-2023	10-Q
11	02-24-2023	12-31-2022	10-K
12	10-28-2022	09-30-2022	10-Q
13	08-02-2022	06-30-2022	10-Q
14	05-02-2022	03-31-2022	10-Q
15	03-14-2022	12-31-2021	10-K
16	11-02-2021	09-30-2021	10-Q
17	08-04-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-18-2021	12-31-2020	10-K
20	11-02-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	02-18-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-01-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	02-27-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	03-22-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-03-2017	06-30-2017	10-Q
34	05-15-2017	03-31-2017	10-Q
35	03-21-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	03-17-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barclays Initiates Coverage On Oruka Thera...
10/13/2025 12:07:33

Barclays analyst Etzer Darout initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Overweight rating and announces ...

stock-market-today-dow-jones-nasdaq-futures-gain-as-government-enters-2nd-week-of-shutdownplug-lithium-americas-uipath-in-focus-updated

Stock Market Today: Dow Jones, Nasdaq, Fut...
10/06/2025 12:23:30

Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Monday fol...

constellation-brands-aehr-test-systems-and-3-stocks-to-watch-heading-into-monday

Constellation Brands, Aehr Test Systems An...
10/06/2025 02:41:09

US stock futures up, focus on Constellation Brands, SkyWater Tech, Aehr Test Systems, Oruka Therapeutics and VCI Global earnings.

Oruka Therapeutics Files For Mixed Shelf O...
10/03/2025 21:32:27

https://www.sec.gov/Archives/edgar/data/907654/000121390025096198/ea0260073-s3_oruka.htm

BTIG Reiterates Buy on Oruka Therapeutics,...
09/29/2025 10:21:46

BTIG analyst Julian Harrison reiterates Oruka Therapeutics (NASDAQ: ORKA) with a Buy and maintains $56 price target.

lyft-oruka-therapeutics-roivant-sciences-workday-and-other-big-stocks-moving-higher-on-wednesday

Lyft, Oruka Therapeutics, Roivant Sciences...
09/17/2025 14:12:52

Clear Street Maintains Buy on Oruka Therap...
09/17/2025 13:54:20

Clear Street analyst Kaveri Pohlman maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $46 price target.

12 Health Care Stocks Moving In Wednesday'...
09/17/2025 12:12:13

why-new-fortress-energy-shares-are-trading-higher-by-41-here-are-20-stocks-moving-premarket

Why New Fortress Energy Shares Are Trading...
09/17/2025 09:15:17

Oruka Therapeutics Interim Phase 1 Data Sh...
09/17/2025 06:13:18

Oruka Therapeutics Secures $180M Private P...
09/17/2025 06:12:32

HC Wainwright & Co. Reiterates Buy on Oruk...
08/18/2025 11:10:27

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $45 ...

Oruka Therapeutics Q2 EPS $(0.46) Beats $(...
08/11/2025 20:15:58

Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(...

HC Wainwright & Co. Reiterates Buy on Oruk...
07/23/2025 10:30:53

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $45 pri...

Oruka Therapeutics Receives FDA Clearance ...
07/21/2025 11:07:56

Oruka Therapeutics Promotes Laura Sandler ...
07/01/2025 20:02:31

Oruka Therapeutics Initiates Dosing Of Hea...
05/20/2025 20:04:05

Wedbush Reiterates Outperform on Oruka The...
05/15/2025 14:55:36

Wedbush analyst Martin Fan reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Outperform and maintains $40 price target.

Oruka Therapeutics Q1 EPS $(0.40) Beats $(...
05/14/2025 20:43:34

Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(...

why-gamestop-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Why GameStop Shares Are Trading Higher By ...
03/26/2025 08:59:57